Diverticular disease of colon. Unresolved issues
https://doi.org/10.33667/2078-5631-2019-2-27(402)-26-31
Abstract
Diverticular disease of the colon is one of the common diseases of the intestine, which is caused by the formation of bag-shaped diverticula in the wall of the colon. The article discusses the clinic, diagnosis, treatment of various clinical forms of diverticular disease. A review of clinical trials of the efficacy of the nonabsorbable antibiotic Rifaximin-alpha is presented. The concept of a microbiome and its functions is given. The article substantiates the appointment of dietary fiber for diverticular disease.
About the Authors
N. V. Orlova
Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Moscow
Russian Federation
Moscow
D. V. Lukanin
Russian National Research Medical University n. a. N. I. Pirogov
Russian Federation
Moscow
Russian Federation
Moscow
References
1. T. Murphy, R. H. Hunt, M. Fried, J. H. Krabshuis. Практическое руководство Всемирной организации гастроэнтерологов (ВОГ-OMGE). Дивертикулярная болезнь.
2. Клинические рекомендации по диагностике и лечению взрослых пациентов дивертикулярной болезнью ободочной кишки. Общероссийская общественная организация «Ассоциация колопроктологов России». — 2013. — 22 стр.
3. Е. А. Сабельникова. Актуальные вопросы лечения и профилактики дивертикулярной болезни. — Эффективная фармакотерапия. — Гастроэнтерология. — № 2 (16). — 2018.
4. Васильченко С. А. Случай ультразвуковой диагностики дивертикулита толстой кишки. / Васильченко С. А., Бурков С. Г., Гурова Н. Ю. и др. / Sonoace-ultrasound — 2010 — № 20 — Стр. 49–54.
5. М. А. Осадчук, А. А. Свистунов. Дивертикулярная болезнь толстой кишки: эпидемия ХХI века. Гастроэнтерология. 2014. Спецвыпуск № 1, Стр. 10–16.
6. М. Д. Ардатская. Дивертикулярная болезнь толстой кишки: решенные и нерешенные вопросы. Медицинский совет. 2017 — № 15. — с. 68–72.
7. Дивертикулярная болезнь толстой кишки. Учебное пособие для врачей. Маев И. В., Дичева Д. Т., Андреев Д. Н., Лебедева Е. Г., Баева Т. А. 2015–23 стр.
8. FR Ponziani, MA Zocco, F D’Aversa, M Pompili, A Gasbarrini. Eubiotic properties of rifaximin: Disruption of the traditional concepts in gut microbiota modulation. World Journal of Gastroenterology 23 (25), 4491–4499.
9. Stallinger S., Eller N., Högenauer C. Non-interventional study evaluating efficacy and tolerability of rifaximin for treatment of uncomplicated diverticular disease // Wien. Klin. Wochenschr. 2014. Vol. 126. № 1–2. P. 9–14.
10. Lanas A. et al. One year intermittent rifaximin plus fibre supplementation vs. fibre supplementation alone to prevent diverticulitis recurrence: A proof-of-concept study. Digestive and Liver Disease, 45, 2: 104–109.
11. Carmelo Scarpignato, G Barbara, A. Iriarte Lanas, Lisa L. Strate. Management of colonic diverticular disease in the third millennium: Highlights from a symposium held during the United European Gastroenterology Week 2017. Therapeutic advances in gastroenterology — 2018. — Vol. 11: 1–21.
12. K. Adamberg, K. Kolk, M. Jaagura, R. Vilu. The composition and metabolism of faecal microbiota is specifically modulated by different dietary polysaccharides and mucin: an isothermal microcalorimetry study. Benef Microb 9 (1): 21–34.
13. Bianchi M. et al. Meta-analysis: longterm therapy with rifaximinin the management of uncomplicated diverticular disease. Aliment Pharmacol Ther 2011; 33: 902–910.
14. Drago-Serrano M. E. Lactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections / M. E. Drago-Serrano, R. Campos-Rodríguez, J. C. Carrero, M. de la Garza // Int. J. Mol. Sci. — 2017 Mar 1. — № 18 (3). — РII: E 501. — DOI: 10.3390/ijms18030501.
15. Mayeur S, Spahis S, Pouliot Y, Levy E. Lactoferrin, a pleiotropic protein in health and disease. Antioxid Redox Signal (2016) 24: 813–36. DOI: 10.1089/ars.2015.6458.
16. Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P. Lactoferrin: A Natural Glycoprotein Involved in Iron and Inflammatory Homeostasis. Int J Mol Sci. 2017. Sep 15; 18 (9).
17. Saeed F., Pasha I., Anjum F. M., Sultan M. T., 2011, Arabinoxylans and arabinogalactans: a comprehensive treatise, Crit Rev Food Sci Nutr 51 (5), 467–476.
18. Terpend, K., Possemiers, S., Daguet, D., & Marzorati, M. Arabinogalactan and fructo-oligosaccharides have a different fermentation profile in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME ® ). Environmental Microbiology Reports. — 2013. — 5 (4) — 595–603.
19. Colecchia A, Vestito A, Pasqui F, et al. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease. World Journal of Gastroenterology: WJG. 2007; 13 (2): 264–269. DOI: 10.3748/wjg.v13.i2.264.
Review
For citations:
Orlova N.V., Lukanin D.V. Diverticular disease of colon. Unresolved issues. Medical alphabet. 2019;2(27):26-31. (In Russ.) https://doi.org/10.33667/2078-5631-2019-2-27(402)-26-31
Views:
486
Email this article 